Feasibility and Utility of a Flexible Outcome Assessment Battery for Longitudinal Traumatic Brain Injury Research: A TRACK-TBI Study.


Journal

Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626

Informations de publication

Date de publication:
02 2023
Historique:
pmc-release: 01 02 2024
pubmed: 14 9 2022
medline: 4 2 2023
entrez: 13 9 2022
Statut: ppublish

Résumé

The effects of traumatic brain injury (TBI) are difficult to measure in longitudinal cohort studies, because disparate pre-injury characteristics and injury mechanisms produce variable impairment profiles and recovery trajectories. In preparation for the Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study, which followed patients with injuries ranging from uncomplicated mild TBI to coma, we designed a multi-dimensional Flexible outcome Assessment Battery (FAB). The FAB relies on a decision-making algorithm that assigns participants to a Comprehensive (CAB) or Abbreviated Assessment Battery (AAB) and guides test selection across all phases of recovery. To assess feasibility of the FAB, we calculated the proportion of participants followed at 2 weeks (2w) and at 3, 6, and 12 months (3m, 6m, 12m) post-injury who completed the FAB and received valid scores. We evaluated utility of the FAB by examining differences in 6m and 12m Glasgow Outcome Scale-Extended (GOSE) scores between participant subgroups derived from the FAB-enabled versus traditional approach to outcome assessment applied at 2w. Among participants followed at 2w (

Identifiants

pubmed: 36097759
doi: 10.1089/neu.2022.0141
pmc: PMC9902043
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

337-348

Subventions

Organisme : NINDS NIH HHS
ID : U01 NS086090
Pays : United States

Références

J Neurotrauma. 2012 Jan 1;29(1):59-65
pubmed: 21663544
Eur J Phys Rehabil Med. 2019 Feb;55(1):139-140
pubmed: 30376271
J Neurotrauma. 2019 Oct 1;36(19):2743-2752
pubmed: 31062649
J Neurotrauma. 2017 Jun 8;:
pubmed: 28595478
J Neurotrauma. 2012 Jan 1;29(1):32-46
pubmed: 21545277
J Neurotrauma. 2020 Jan 15;37(2):357-365
pubmed: 31502498
J Neurol. 2020 May;267(5):1245-1254
pubmed: 31773246
J Neurotrauma. 1998 Aug;15(8):573-85
pubmed: 9726257
Brain Inj. 2015;29(11):1259-72
pubmed: 26274493
Arch Phys Med Rehabil. 2013 Oct;94(10):1855-60
pubmed: 23732164
Science. 1974 Sep 27;185(4157):1124-31
pubmed: 17835457
Arch Phys Med Rehabil. 2020 Nov;101(11):2041-2050
pubmed: 32738198
Arch Phys Med Rehabil. 2021 Jan;102(1):87-96
pubmed: 33022273
J Neurotrauma. 2019 Apr 1;36(7):1136-1146
pubmed: 30226400
J Neurotrauma. 2021 Apr 15;38(8):1048-1059
pubmed: 33107388
J Neurotrauma. 2013 Nov 15;30(22):1831-44
pubmed: 23815563
J Int Neuropsychol Soc. 2004 Oct;10(6):807-17
pubmed: 15637771
Neurotherapeutics. 2010 Jan;7(1):115-26
pubmed: 20129503
J Neurotrauma. 2013 Nov 15;30(22):1852-61
pubmed: 23725058
J Neurotrauma. 2018 May 15;35(10):1138-1145
pubmed: 29648959
Neurology. 2010 Jul 20;75(3):246-52
pubmed: 20554940
J Neurotrauma. 1998 Sep;15(9):685-92
pubmed: 9753216
Arch Phys Med Rehabil. 2005 May;86(5):896-904
pubmed: 15895334
J Neurotrauma. 2020 Feb 15;37(4):675-679
pubmed: 31663425
JAMA. 2012 Nov 21;308(19):1993-2000
pubmed: 23168823
J Neurotrauma. 2021 Jan 15;38(2):261-271
pubmed: 33023400
J Neurotrauma. 2021 Sep 1;38(17):2435-2446
pubmed: 33740873
J Neurotrauma. 2021 Sep 1;38(17):2419-2434
pubmed: 33832330
J Head Trauma Rehabil. 2018 May/Jun;33(3):147-157
pubmed: 29385010
J Neurotrauma. 2008 Jul;25(7):719-38
pubmed: 18627252
Arch Phys Med Rehabil. 2004 Dec;85(12):2020-9
pubmed: 15605342
J Neurosurg. 1990 Nov;73(5):699-709
pubmed: 2213159
Nat Rev Neurol. 2015 Feb;11(2):71-2
pubmed: 25582447

Auteurs

Yelena G Bodien (YG)

Massachusetts General Hospital, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
Spaulding Rehabilitation Hospital, Charlestown, Massachusetts, USA.

Jason Barber (J)

University of Washington, Seattle, Washington, USA.

Sabrina R Taylor (SR)

University of California, San Francisco, San Francisco, California, USA.

Kim Boase (K)

University of Washington, Seattle, Washington, USA.

John D Corrigan (JD)

The Ohio State University, Columbus, Ohio, USA.

Sureyya Dikmen (S)

University of Washington, Seattle, Washington, USA.

Raquel C Gardner (RC)

University of California, San Francisco, San Francisco, California, USA.

Joel H Kramer (JH)

University of California, San Francisco, San Francisco, California, USA.

Harvey Levin (H)

Baylor College of Medicine, Houston, Texas, USA.

Joan Machamer (J)

University of Washington, Seattle, Washington, USA.

Thomas McAllister (T)

University of Indiana School of Medicine, Indianapolis, Indiana, USA.

Lindsay D Nelson (LD)

Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Laura B Ngwenya (LB)

University of Cincinnati, Cincinnati, Ohio, USA.

Mark Sherer (M)

Baylor College of Medicine, Houston, Texas, USA.
TIRR Memorial Hermann, Houston, Texas, USA.

Murray B Stein (MB)

University of California San Diego, La Jolla, California, USA.

Mary Vassar (M)

University of California, San Francisco, San Francisco, California, USA.

John Whyte (J)

Moss Rehabilitation Research Institute, Elkins Park, Pennsylvania, USA.

John K Yue (JK)

University of California, San Francisco, San Francisco, California, USA.

Amy Markowitz (A)

University of California, San Francisco, San Francisco, California, USA.

Michael A McCrea (MA)

Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Geoffrey T Manley (GT)

University of California, San Francisco, San Francisco, California, USA.

Nancy Temkin (N)

University of Washington, Seattle, Washington, USA.

Joseph T Giacino (JT)

Massachusetts General Hospital, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
Spaulding Rehabilitation Hospital, Charlestown, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH